| |
Characteristic
|
CRC
|
Polyps
|
Controls
|
|---|
|
Series 1
| |
n = 9
|
n = 10
|
n = 30
|
| |
Sex
| | | |
| |
Male
|
3
|
6
|
15
|
| |
Female
|
6
|
4
|
15
|
| |
Age
| | | |
| |
Mean ± SD
|
66.1 ± 17.2
|
71.5 ± 11.8
|
62. 1 ± 17.3
|
| |
Range
|
36-94
|
56-91
|
22-91
|
| |
Stage
| | | |
| |
I/II
|
4 (1/3)
|
Na
|
Na
|
| |
III/IV
|
5 (1/4)
|
Na
|
Na
|
|
Series 2
| |
n = 23
|
n = 16
|
n = 131
|
| |
Sex
| | | |
| |
Male
|
18
|
10
|
71
|
| |
Female
|
5
|
6
|
60
|
| |
Age
| | | |
| |
Mean ± SD
|
68.6 ± 11.2
|
61.8 ± 9.2
|
58.5 ± 16.3
|
| |
Range
|
51-84
|
52-85
|
18-94
|
| |
Stage
| | | |
| |
I/II
|
2 (1/1)
|
Na
|
Na
|
| |
III/IV
|
21 (6/15)
|
Na
|
Na
|
|
Series 1 + 2 pooled
| |
n = 32
|
n =26
|
n = 161
|
| |
Sex
| | | |
| |
Male
|
21
|
16
|
86
|
| |
Female
|
11
|
10
|
75
|
| |
Age
| | | |
| |
Mean ± SD
|
67.9 ± 12.9
|
65.5 ± 11.1
|
59.1 ± 16.5
|
| |
Range
|
36-94
|
52-91
|
18-94
|
| |
Stage
| | | |
| |
I/II
|
6 (2/4)
|
Na
|
Na
|
| |
III/IV
|
26 (7/19)
|
Na
|
Na
|
